These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34931458)

  • 61. Less invasive surfactant administration and complications of preterm birth.
    Härtel C; Paul P; Hanke K; Humberg A; Kribs A; Mehler K; Vochem M; Wieg C; Roll C; Herting E; Göpel W
    Sci Rep; 2018 May; 8(1):8333. PubMed ID: 29844331
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment and outcome data of very low birth weight infants treated with less invasive surfactant administration in comparison to intubation and mechanical ventilation in the clinical setting of a cross-sectional observational multicenter study.
    Langhammer K; Roth B; Kribs A; Göpel W; Kuntz L; Miedaner F
    Eur J Pediatr; 2018 Aug; 177(8):1207-1217. PubMed ID: 29808237
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Less invasive surfactant administration (LISA): chances and limitations.
    Herting E; Härtel C; Göpel W
    Arch Dis Child Fetal Neonatal Ed; 2019 Nov; 104(6):F655-F659. PubMed ID: 31296694
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Less-Invasive Surfactant Administration for Neonatal Respiratory Distress Syndrome: A Consensus Guideline.
    Reynolds P; Bustani P; Darby C; Fernandez Alvarez JR; Fox G; Jones S; Robertson SJ; Vasu V; Roehr CC
    Neonatology; 2021; 118(5):586-592. PubMed ID: 34515188
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial.
    Oncel MY; Arayici S; Uras N; Alyamac-Dizdar E; Sari FN; Karahan S; Canpolat FE; Oguz SS; Dilmen U
    Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F323-8. PubMed ID: 26553376
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Risk factors for minimally invasive surfactant administration failure in preterm infants with respiratory distress syndrome].
    Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FQ; Guo W; Li L; Xiao M; Liu WL; Jiang R
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Mar; 22(3):231-237. PubMed ID: 32204759
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical evaluation of an application aid for less-invasive surfactant administration (LISA).
    Maiwald CA; Neuberger P; Franz AR; Engel C; Vochem M; Poets CF; ;
    Arch Dis Child Fetal Neonatal Ed; 2021 Mar; 106(2):211-214. PubMed ID: 33023914
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of LISA versus InSurE: A single center experience.
    Queliz T; Perez JA; Corrigan MJ
    J Neonatal Perinatal Med; 2021; 14(4):503-509. PubMed ID: 33646183
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.
    Isayama T; Iwami H; McDonald S; Beyene J
    JAMA; 2016 Aug; 316(6):611-24. PubMed ID: 27532916
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Respiratory distress syndrome in preterm infants of less than 32 weeks: What difference does giving 100 or 200 mg/kg of exogenous surfactant make?
    Lanciotti L; Correani A; Pasqualini M; Antognoli L; Dell'Orto VG; Giorgetti C; Colombo S; Palazzi ML; Rondina C; Burattini I; Carnielli VP
    Pediatr Pulmonol; 2022 Sep; 57(9):2067-2073. PubMed ID: 35577766
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Application of three kinds of non-invasive positive pressure ventilation as a primary mode of ventilation in premature infants with respiratory distress syndrome: a randomized controlled trial].
    Gao X; Yang B; Hei M; Cui X; Wang J; Zhou G; Qu S
    Zhonghua Er Ke Za Zhi; 2014 Jan; 52(1):34-40. PubMed ID: 24680406
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of different surfactant administrations on cerebral autoregulation in preterm infants with respiratory distress syndrome.
    Li XF; Cheng TT; Guan RL; Liang H; Lu WN; Zhang JH; Liu MY; Yu X; Liang J; Sun L; Zhang L
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):801-805. PubMed ID: 27924521
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia: a case-control study.
    Te Pas AB; Lopriore E; Engbers MJ; Walther FJ
    PLoS One; 2007 Feb; 2(2):e192. PubMed ID: 17285145
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Premedication practices for less invasive surfactant administration - results from a nationwide cohort study.
    Krajewski P; Szpecht D; Hożejowski R
    J Matern Fetal Neonatal Med; 2022 Dec; 35(24):4750-4754. PubMed ID: 33356691
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Continuous distending pressure for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: a retrospective cohort study.
    Paul S; Rao S; Kohan R; McMichael J; French N; Zhang G; Simmer K
    J Paediatr Child Health; 2013 Oct; 49(10):839-44. PubMed ID: 23802801
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis.
    Moschino L; Ramaswamy VV; Reiss IKM; Baraldi E; Roehr CC; Simons SHP
    Pediatr Res; 2023 Feb; 93(3):471-491. PubMed ID: 35654833
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
    J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial.
    Ramanathan R; Biniwale M; Sekar K; Hanna N; Golombek S; Bhatia J; Naylor M; Fabbri L; Varoli G; Santoro D; Del Buono D; Piccinno A; Dammann CE
    J Pediatr; 2020 Oct; 225():90-96.e1. PubMed ID: 32553868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.